PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Geiger, C. ; Nößner, E. ; Frankenberger, B. ; Falk, C.S.* ; Pohla, H.* ; Schendel, D.J.

Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

J. Mol. Med. 87, 595-612 (2009)
Verlagsversion DOI PMC
Closed
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The development of immunotherapies for renal cell carcinoma (RCC) has been the subject of research for several decades. In addition to cytokine therapy, the benefit of various adoptive cell therapies has again come into focus in the past several years. Nevertheless, success in fighting this immunogenic tumor is still disappointing. RCC can attract a multitude of different effector cells of both the innate and adaptive immune system, including natural killer (NK) cells, gamma delta T cells, NK-like T cells, peptide-specific T cells, dendritic cells (DC), and regulatory T cells (Tregs). Based on intensive research on the biology and function of different immune cells, we now understand that individual cell types do not act in isolation but function within a complex network of intercellular interactions. These interactions play a pivotal role in the efficient activation and function of effector cells, which is a prerequisite for successful tumor elimination. This review provides a current overview of the diversity of effector cells having the capacity to recognize RCC. Aspects of the functions and anti-tumor properties that make them attractive candidates for adoptive cell therapies, as well as experience in clinical application are discussed. Improved knowledge of the biology of this immune network may help us to effectively harness various effector cells, placing us in a better position to develop new therapeutic strategies to successfully fight RCC.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.370
1.320
10
10
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Renal cell carcinoma; Adoptive cell therapy; T cell; Natural killer cell; Dendritic cell; Immunotherapy; tumor-infiltrating lymphocytes; regulatory t-cells; natural-killer-cells; minor histocompatibility antigens; high-dose interleukin-2; mature dendritic cells; carbonic-anhydrase-ix; open reading frame; hla class-i; clinical-applications
Sprache englisch
Veröffentlichungsjahr 2009
HGF-Berichtsjahr 0
ISSN (print) / ISBN 0946-2716
e-ISSN 1432-1440
Zeitschrift Journal of Molecular Medicine
Quellenangaben Band: 87, Heft: 6, Seiten: 595-612 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort Heidelberg
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Immunology (IMI)
CCG Immune Monitoring (Platform) (IMI-KIM)
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501700-001
G-501700-002
G-520400-001
G-501700-005
PubMed ID 19271159
DOI 10.1007/s00109-009-0455-2
Scopus ID 67349262324
Erfassungsdatum 2009-07-09
[➜Korrektur melden]